Added value of a mandible movement automated analysis (MMAA) to a type 3 portable monitoring (PM) in the diagnosis of obstructive sleep apnea (OSA) Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea Year: 2011
Study of inflammatory markers (C-reactive protein & tumor necrosis factor-α) in moderate to severe obstructive sleep apnea hypopnea syndrome (OSAHS) and their response to treatment with nasal continuous positive airway pressure (nCPAP) Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Usefulness of clinical and overnight oximetry (OO) parameters in the prediction of apnoea-hyponoea index (AHI) in Chinese patients with suspected obstructive sleep apnoea (OSA) Source: Eur Respir J 2001; 18: Suppl. 33, 216s Year: 2001
Upper airway (UAW) pressure-flow response to electrical stimulation (ES) of tongue protrusors (TP) and retractors (TR) in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2001; 18: Suppl. 33, 332s Year: 2001
Clinical value of polymesam recording in diagnosis of obstructive sleep apnoea (OSA). Can we replace polysomnography (PSG) with polymesam (PM)? Source: Eur Respir J 2001; 18: Suppl. 33, 91s Year: 2001
Longterm [7 year] follow-up of patients fitted with a non-adjustable intra-oral device (IOD) for snoring/obstructive sleep apnoea (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 477s Year: 2004
Predicting effect of mandibular advancement device (MAD) in sleep apnea (SA) or symptomatic snoring (SS) patients using computational fluid dynamics (CFD) Source: Annual Congress 2005 - Upper airway interventions in OSA patients Year: 2005
Effect of nCPAP on work performance (WP) in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 725s Year: 2005
Treatment of obstructive sleep apnoea syndrome (OSAS) with uvulo palatal flep (UPF) Source: Eur Respir J 2003; 22: Suppl. 45, 96s Year: 2003
Prevalence and causes of residual sleepiness (RS) 12 months after continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea syndome (OSAS) Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness Year: 2010
C-reactive protein (CRP) levels in obese patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
Is obstructive sleep apnoea (OSA) associated with insulin resistance (IR) in severely obese adults? Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders Year: 2003
Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005
A novel machine learning approach to predict oral appliance (OA) therapy responses in obstructive sleep apnoea (OSA) Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021
Reliability of the apnoea-hypopnoea index (AHI) reported by ventilator software in patients with obesity hypoventilation syndrome (OHS) treated with long-term noninvasive ventilation (NIV) Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes Year: 2013
Helical CT to assess mandibular advancement device (MAD) effectiveness in obstructive sleep apnea (OSA) Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
Frequency of metabolic syndrome (MS) in patients with obstructive sleep apnoea (OSA) depends on adopted definition Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010
Interaction between body weight obstructive sleep apnea (OSA) on C-reactive protein (CRP) in an otherwise healthy population: The EPIOSA study Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing Year: 2015
LATE-BREAKING ABSTRACT: 2-years follow-up (FU) results of ORCADES study: Long-term mandibular repositioning device (MRD) therapy in patients treated for obstructive sleep apnea (OSA) Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome Year: 2016
C-reactive protein (CRP) levels in obstructive sleep apnea (OSA) patients and relation to severity of OSA Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011